The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

被引:91
|
作者
Parish, Sarah [1 ]
Peto, Richard
Palmer, Alison
Clarke, Robert
Lewington, Sarah
Offer, Alison
Whitlock, Gary
Clark, Sarah
Youngman, Linda
Sleight, Peter
Collins, Rory
机构
[1] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England
基金
英国医学研究理事会;
关键词
Myocardial infarction; Lipoproteins; Lipids; Cholesterol; Risk factors; CHEMISTRY STANDARDIZATION PROJECT; INTERNATIONAL-FEDERATION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; A-I; PLASMA; COMPARABILITY; LIPOPROTEINS; ASSOCIATIONS; THERAPY;
D O I
10.1093/eurheartj/ehp221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma levels of apolipoprotein B (apoB), the main surface protein on LDL particles, and LDL-C, the amount of cholesterol in those particles, are closely correlated and, considered separately, are positive risk factors. Plasma levels of apolipoprotein A(1), the main surface protein on HDL particles, and HDL-C, the amount of cholesterol in those particles, are also closely correlated with each other and, considered separately, are negative risk factors. The interdependence of these four risk factors is unclear. Case-control study among 3510 acute myocardial infarction patients (without prior vascular disease, diabetes, or statin use) in UK hospitals and 9805 controls. Relative risks (age, sex, smoking, and obesity-adjusted) were more strongly related to apoB than to LDL-C and, given apoB, more strongly negatively related to apoA(1) than to HDL-C. The ratio apoB/apoA(1) was uncorrelated with time since symptom onset in cases, was reproducible in samples collected a few years apart in controls (correlation 0.81), and encapsulated almost all the predictive power of these four measurements. Its effect was continuous, substantial throughout the UK normal range [relative risk, top vs. bottom decile of this ratio, 7.3 (95% CI 5.8-9.2)] and varied little with age. The ratio apoB/apoA(1) was substantially more informative about risk (chi 12 = 550) than were commonly used measures such as LDL-C/HDL-C, total/HDL cholesterol, non-HDL cholesterol, and total cholesterol (chi 12 = 407, 334, 204, and 105, respectively). Given apoB and apoA(1), the relationship with risk of LDL-C was reversed, and this reversal was strengthened by appropriate allowance for random measurement errors in two correlated variables. Given usual apoB, lower LDL-C (consistent with smaller LDL particles) was associated with higher risk (P < 0.0001). During the first 8 h after symptom onset HDL-C increased by about 10%, precluding reliable assessment of the joint relationship of apoA(1) and pre-onset HDL-C with risk in such retrospective case-control studies. Apolipoprotein ratios are more informative about risk than lipid fractions are. This suggests that, among lipoprotein particles of a particular type (LDL or HDL), some smaller and larger subtypes differ in their effects on risk. Direct measurements of even more specific subtypes of lipoprotein particles may be even more informative about risk.
引用
收藏
页码:2137 / 2146
页数:10
相关论文
共 49 条
  • [21] Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials
    Jovanovski, Elena
    Yashpal, Shahen
    Komishon, Allison
    Zurbau, Andreea
    Mejia, Sonia Blanco
    Hoang Vi Thanh Ho
    Li, Dandan
    Sievenpiper, John
    Duvnjak, Lea
    Vuksan, Vladimir
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (05) : 922 - 932
  • [22] Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia
    Ganda, O. P.
    Jumes, C. G.
    Abrahamson, M. J.
    Molla, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (01) : 51 - 56
  • [23] Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease
    Pan, Liting
    Lu, Guoping
    Chen, Zhenyue
    CORONARY ARTERY DISEASE, 2014, 25 (05) : 433 - 438
  • [24] Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients
    Soran, Handrean
    France, Michael W.
    Kwok, See
    Dissanayake, Sanjaya
    Charlton-Menys, Valentine
    Younis, Nahla N.
    Durrington, Paul N.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 566 - 571
  • [25] Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness
    Qu, Geyue
    Zhang, Zhongying
    Zhu, Hong
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [26] Correlation Between Reductions in LDL-cholesterol, Apolipoprotein B, and Lipoprotein(a) with Mipomersen in FH and Other Hypercholesterolemic Patients at High Risk for Coronary Disease
    Santos, Raul D.
    Raal, Frederick J.
    CIRCULATION, 2012, 126 (21)
  • [27] Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
    Gibson, C. Michael
    Duffy, Danielle
    Bahit, Maria Cecilia
    Chi, Gerald
    White, Harvey
    Korjian, Serge
    Alexander, John H.
    Lincoff, A. Michael
    Heise, Mark
    Kingwell, Bronwyn A.
    Nicolau, Jose C.
    Lopes, Renato D.
    Cornel, Jan H.
    Lewis, Basil S.
    Vinereanu, Dragos
    Goodman, Shaun G.
    Bode, Christoph
    Steg, Ph Gabriel
    Libby, Peter
    Sacks, Frank M.
    Bainey, Kevin R.
    Ridker, Paul M.
    Mahaffey, Kenneth W.
    Aylward, Philip
    Nicholls, Stephen J.
    Pocock, Stuart J.
    Mehran, Roxana
    Harrington, Robert A.
    EUROPEAN HEART JOURNAL, 2024, : 5023 - 5038
  • [28] Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: Population-based cohort study
    Onat, Altan
    Can, Gunay
    Cicek, Gokhan
    Ayhan, Erkan
    Dogan, Yuksel
    CLINICAL BIOCHEMISTRY, 2010, 43 (18) : 1381 - 1386
  • [29] Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With Replication
    Chasman, Daniel I.
    Pare, Guillaume
    Zee, Robert Y. L.
    Parker, Alex N.
    Cook, Nancy R.
    Buring, Julie E.
    Kwiatkowski, David J.
    Rose, Lynda M.
    Smith, Joshua D.
    Williams, Paul T.
    Rieder, Mark J.
    Rotter, Jerome I.
    Nickerson, Deborah A.
    Krauss, Ronald M.
    Miletich, Joseph P.
    Ridker, Paul M.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2008, 1 (01) : 21 - U115
  • [30] Fibrinogen to HDL-Cholesterol ratio as a predictor of mortality risk in patients with acute myocardial infarction
    Jia, Congzhuo
    Wu, Wanying
    Lu, Huan
    Liu, Jin
    Chen, Shiqun
    Liang, Guoxiao
    Zhou, Yang
    Yu, Sijia
    Qiao, Linfang
    Chen, Jinming
    Tan, Ning
    Liu, Yong
    Chen, Jiyan
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)